{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:31:53Z","timestamp":1793460713337,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidade Federal De Alfenas","id":[{"id":"https:\/\/ror.org\/034vpja60","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Purinergic signalling plays a central regulatory role on cell proliferation, migration, differentiation, survival, and inflammation.\u00a0However, the impact of purinergic modulators-based therapies on tissue repair is still overlooked. By using a systematic review framework, we investigated the therapeutic relevance of purinergic agonists and antagonists in animal models of skin wound healing. Following PRISMA guidelines, PubMed\/Medline, Scopus, Web of Science, Embase, and CINAHL databases were searched, identifying 12 in vivo preclinical studies. Risk of bias was assessed using the SYRCLE tool. Topical or oral administration of CGS-21680 (4-[{\n                    <jats:italic>N<\/jats:italic>\n                    -ethyl-5\n                    <jats:italic>\u2019<\/jats:italic>\n                    -carbamoyladenos-2-yl}aminoethyl] phenylpropionic acid), UTP (Uridine-5'-triphosphate), NECA (5'-N-ethylcarboxamidoadenosine), ATP (adenosine triphosphate), PDRN (polydeoxyribonucleotide), ADP (Adenosine-5'-diphosphate) and TMPS (Thymidine 5'-O-monophosphorothioate) agonists stimulated wound contraction, fibroblast and keratinocyte proliferation, angiogenesis, and collagen biosynthesis. These effects were associated with activation of Nrf2 (Nuclear factor erythroid 2\u2013related factor 2), MAPK (Mitogen-Activated Protein Kinase), and ERK\/CREB pathways,  inflammation and oxidative\/nitrosative stress\u00a0down-regulation, and increased anti-inflammatory\/regulatory cytokines (IL-10, IL-13, TGF-\u03b2) and growth factors (FGF, EGF). Conversely, the purinergic antagonists\u00a0DMPX (3,7-dimethyl-1-propargylxanthine), CSC (8-(3-chlorostyryl) caffeine), SUR (Suramin), ENP (enprofylline), caffeine, CLOP (clopidogrel), MRS 2179 (2\u2032-deoxy-N6-methyladenosine-3\u2032,5\u2032-bisphosphate), and MRS 2395 (2-Chloro-3\u2032,5\u2032-O-(benzoyl-\u03b2,\u03b3-methylene) adenosine 5\u2032-triphosphate), as well as   genetic knockout for purinergic receptors delayed wound closure by inhibiting these pathways, impairing angiogenesis, collagenogenesis, and aggravating inflammation and oxidative damage. Purinergic\u00a0agonists were associated with improved wound healing through inflammatory and oxidative modulation, enhanced angiogenesis, increased cell proliferation, and accelerated wound closure, whereas antagonists or genetic deficiency of purinergic receptors impaired tissue repair. This review was registered in the PROSPERO database (CRD420251010254).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>\n                  <jats:p>Overview of the effects of purinergic signalling modulation on cutaneous wound healing in murine models. Purinergic receptor activation by agonists accelerates wound closure, enhances cell proliferation and angiogenesis, and attenuates oxidative stress and pro-inflammatory cytokine production through activation of the PKA\/ERK\/CREB pathway. Conversely, receptor inhibition by antagonists or genetic deletion (KO) disrupts downstream signalling, resulting in delayed wound healing and increased inflammatory and oxidative damage.<\/jats:p>","DOI":"10.1007\/s11302-026-10178-y","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:15:15Z","timestamp":1788189315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interaction between purinergic signalling and purinergic modulators with skin wound repair effectors: a systematic review of preclinical in vivo models"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4051-1600","authenticated-orcid":false,"given":"Silv\u00e2nia M\u00f3l","family":"Pelinsari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reggiani Vilela","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"da Silva Mattosinhos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00e1urea Matias","family":"Sarandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerson Ferreira","family":"Vilela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f4mulo Dias","family":"Novaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"10178_CR1","doi-asserted-by":"publisher","first-page":"2402711","DOI":"10.1002\/adhm.202402711","volume":"14","author":"GJ Duarte","year":"2025","unstructured":"Duarte GJ, Piedade AP, Sarmento B, Mascarenhas-Melo F (2025) The printed path to healing: advancing wound dressings through additive manufacturing. Adv Healthc Mater 14:2402711. https:\/\/doi.org\/10.1002\/adhm.202402711","journal-title":"Adv Healthc Mater"},{"key":"10178_CR2","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/iwj.13333","volume":"17","author":"ZJ Lo","year":"2020","unstructured":"Lo ZJ, Lim X, Eng D, Car J, Hong Q, Yong E et al (2020) Clinical and economic burden of wound care in the tropics: a 5-year institutional population health review. Int Wound J 17:790\u2013803. https:\/\/doi.org\/10.1111\/iwj.13333","journal-title":"Int Wound J"},{"key":"10178_CR3","doi-asserted-by":"publisher","first-page":"651740","DOI":"10.3389\/fimmu.2021.651740","volume":"12","author":"PA Borges","year":"2021","unstructured":"Borges PA, Waclawiak I, Georgii JL, Fraga-Junior VDS, Barros JF, Lemos FS, Benjamim CF (2021) Adenosine diphosphate improves wound healing in diabetic mice through P2Y12 receptor activation. Front Immunol 12:651740. https:\/\/doi.org\/10.3389\/fimmu.2021.651740","journal-title":"Front Immunol"},{"key":"10178_CR4","unstructured":"IMARC Group (2024). Wound care market: Global industry trends, share, size, growth, opportunity and forecast 2024\u20132032. Retrieved from https:\/\/www.imarcgroup.com\/wound-care-market Accessed 26 June 2025"},{"key":"10178_CR5","doi-asserted-by":"publisher","first-page":"2404255","DOI":"10.1002\/adhm.202404255","volume":"14","author":"A Chhillar","year":"2025","unstructured":"Chhillar A, Jaiswal A (2025) Hyaluronic acid-based self-healing hydrogels for diabetic wound healing. Adv Healthc Mater 14:2404255. https:\/\/doi.org\/10.1002\/adhm.202404255","journal-title":"Adv Healthc Mater"},{"key":"10178_CR6","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.3390\/ijms25115723","volume":"25","author":"VA B\u0103d\u0103lu\u021b\u0103","year":"2024","unstructured":"B\u0103d\u0103lu\u021b\u0103 VA, Curu\u021biu C, Di\u021bu LM, Holban AM, Laz\u0103r V (2024) Probiotics in wound healing. Int J Mol Sci 25:5723. https:\/\/doi.org\/10.3390\/ijms25115723","journal-title":"Int J Mol Sci"},{"key":"10178_CR7","doi-asserted-by":"publisher","first-page":"e13239","DOI":"10.1111\/wrr.13239","volume":"33","author":"TN Mgwenya","year":"2025","unstructured":"Mgwenya TN, Abrahamse H, Houreld NN (2025) Photobiomodulation studies on diabetic wound healing: an insight into the inflammatory pathway in diabetic wound healing. Wound Repair Regen 33:e13239. https:\/\/doi.org\/10.1111\/wrr.13239","journal-title":"Wound Repair Regen"},{"key":"10178_CR8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/jid.2011.344","volume":"132","author":"G Burnstock","year":"2012","unstructured":"Burnstock G, Knight GE, Greig AV (2012) Purinergic signalling in healthy and diseased skin. J Invest Dermatol 132:526\u2013546. https:\/\/doi.org\/10.1038\/jid.2011.344","journal-title":"J Invest Dermatol"},{"key":"10178_CR9","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/S0002-9440(10)63749-2","volume":"164","author":"MC Montesinos","year":"2004","unstructured":"Montesinos MC, Shaw JP, Yee H, Shamamian P, Cronstein BN (2004) Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. Am J Pathol 164:1887\u20131892. https:\/\/doi.org\/10.1016\/S0002-9440(10)63749-2","journal-title":"Am J Pathol"},{"key":"10178_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","volume":"6","author":"Z Huang","year":"2021","unstructured":"Huang Z, Xie N, Illes P, Di Virgilio F, Ulrich H, Semyanov A, Tang Y (2021) From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Ther 6:162. https:\/\/doi.org\/10.1038\/s41392-021-00553-z","journal-title":"Signal Transduct Target Ther"},{"key":"10178_CR11","doi-asserted-by":"publisher","first-page":"114406","DOI":"10.1016\/j.bcp.2021.114406","volume":"187","author":"LT Woods","year":"2021","unstructured":"Woods LT, Forti KM, Shanbhag VC, Camden JM, Weisman GA (2021) P2Y receptors for extracellular nucleotides: contributions to cancer progression and therapeutic implications. Biochem Pharmacol 187:114406. https:\/\/doi.org\/10.1016\/j.bcp.2021.114406","journal-title":"Biochem Pharmacol"},{"key":"10178_CR12","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/j.0906-6705.2003.00110.x","volume":"12","author":"AV Greig","year":"2003","unstructured":"Greig AV, James SE, McGrouther DA, Terenghi G, Burnstock G (2003) Purinergic receptor expression in the regenerating epidermis in a rat model of normal and delayed wound healing. Exp Dermatol 12:860\u2013871. https:\/\/doi.org\/10.1111\/j.0906-6705.2003.00110.x","journal-title":"Exp Dermatol"},{"key":"10178_CR13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1743-6109.2006.00105.x","volume":"14","author":"M Braun","year":"2006","unstructured":"Braun M, Lelieur K, Kietzmann M (2006) Purinergic substances promote murine keratinocyte proliferation and enhance impaired wound healing in mice. Wound Repair Regen 14:152\u2013161. https:\/\/doi.org\/10.1111\/j.1743-6109.2006.00105.x","journal-title":"Wound Repair Regen"},{"key":"10178_CR14","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1084\/jem.186.9.1615","volume":"186","author":"MC Montesinos","year":"1997","unstructured":"Montesinos MC, Gadangi P, Longaker M, Sung J, Levine J, Nilsen D, Reibman J et al (1997) Wound healing is accelerated by agonists of adenosine A2 (G\u03b1s-linked) receptors. J Exp Med 186:1615\u20131620. https:\/\/doi.org\/10.1084\/jem.186.9.1615","journal-title":"J Exp Med"},{"key":"10178_CR15","doi-asserted-by":"publisher","first-page":"5810","DOI":"10.3390\/ijms25115810","volume":"25","author":"L Chen","year":"2024","unstructured":"Chen L, Lei X, Mahnke K (2024) Adenosine and its receptors in the pathogenesis and treatment of inflammatory skin diseases. Int J Mol Sci 25:5810. https:\/\/doi.org\/10.3390\/ijms25115810","journal-title":"Int J Mol Sci"},{"key":"10178_CR16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1089\/jop.2016.0009","volume":"32","author":"MS Minns","year":"2016","unstructured":"Minns MS, Trinkaus-Randall V (2016) Purinergic signalling in corneal wound healing: a tale of 2 receptors. J Ocul Pharmacol Ther 32:498\u2013503. https:\/\/doi.org\/10.1089\/jop.2016.0009","journal-title":"J Ocul Pharmacol Ther"},{"key":"10178_CR17","doi-asserted-by":"publisher","first-page":"1058371","DOI":"10.3389\/fonc.2023.1058371","volume":"13","author":"J Kaur","year":"2023","unstructured":"Kaur J, Dora S (2023) Purinergic signalling: Diverse effects and therapeutic potential in cancer. Front Oncol 13:1058371. https:\/\/doi.org\/10.3389\/fonc.2023.1058371","journal-title":"Front Oncol"},{"key":"10178_CR18","doi-asserted-by":"publisher","first-page":"1216489","DOI":"10.3389\/fnins.2023.1216489","volume":"17","author":"H Molcak","year":"2023","unstructured":"Molcak H, Jiang K, Campbell CJ, Matsubara JA (2023) Purinergic signalling via P2X receptors and mechanisms of unregulated ATP release in the outer retina and age-related macular degeneration. Front Neurosci 17:1216489. https:\/\/doi.org\/10.3389\/fnins.2023.1216489","journal-title":"Front Neurosci"},{"key":"10178_CR19","doi-asserted-by":"publisher","first-page":"27090","DOI":"10.1074\/jbc.M114.580936","volume":"289","author":"AM Weihs","year":"2014","unstructured":"Weihs AM, Fuchs C, Teuschl AH, Hartinger J, Slezak P, Mittermayr R et al (2014) Shock wave treatment enhances cell proliferation and improves wound healing by ATP release-coupled extracellular signal-regulated kinase (ERK) activation. J Biol Chem 289:27090\u201327104. https:\/\/doi.org\/10.1074\/jbc.M114.580936","journal-title":"J Biol Chem"},{"key":"10178_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11302-016-9498-3","volume":"12","author":"G Shaikh","year":"2016","unstructured":"Shaikh G, Cronstein BN (2016) Signalling pathways involving adenosine A2A and A2B receptors in wound healing and fibrosis. Purinergic Signal 12:191\u2013197. https:\/\/doi.org\/10.1007\/s11302-016-9498-3","journal-title":"Purinergic Signal"},{"key":"10178_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3892\/etm.2025.12844","volume":"29","author":"Q Ming","year":"2025","unstructured":"Ming Q, Li Z, Tan J, Li Y (2025) Adenosine A1 receptor agonist alleviates cerebral ischemia\/reperfusion injury by inhibiting Nrf2\/NLRP3 signaling mediated pyroptosis. Exp Ther Med 29:94. https:\/\/doi.org\/10.3892\/etm.2025.12844","journal-title":"Exp Ther Med"},{"key":"10178_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-94-007-1217-1_6","volume":"55","author":"A van der Vliet","year":"2011","unstructured":"van der Vliet A, Bove PF (2011) Purinergic signaling in wound healing and airway remodeling. Subcell Biochem 55:139\u2013157. https:\/\/doi.org\/10.1007\/978-94-007-1217-1_6","journal-title":"Subcell Biochem"},{"key":"10178_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1096\/fj.15-274563","volume":"30","author":"D Ferrari","year":"2016","unstructured":"Ferrari D, Gambari R, Idzko M, M\u00fcller T, Albanesi C, Pastore S et al (2016) Purinergic signaling in scarring. FASEB J 30:3\u201312. https:\/\/doi.org\/10.1096\/fj.15-274563","journal-title":"FASEB J"},{"key":"10178_CR24","doi-asserted-by":"publisher","first-page":"102137","DOI":"10.1016\/j.redox.2021.102137","volume":"47","author":"LEB Savio","year":"2021","unstructured":"Savio LEB, Leite-Aguiar R, Alves VS, Coutinho-Silva R, Wyse ATS (2021) Purinergic signalling in the modulation of redox biology. Redox Biol 47:102137. https:\/\/doi.org\/10.1016\/j.redox.2021.102137","journal-title":"Redox Biol"},{"key":"10178_CR25","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.jid.2018.10.027","volume":"139","author":"LMB Perera","year":"2019","unstructured":"Perera LMB, Sekiguchi A, Uchiyama A, Uehara A, Fujiwara C, Yamazaki S et al (2019) The regulation of skin fibrosis in systemic sclerosis by extracellular ATP via P2Y2 purinergic receptor. J Invest Dermatol 139:890\u2013899. https:\/\/doi.org\/10.1016\/j.jid.2018.10.027","journal-title":"J Invest Dermatol"},{"key":"10178_CR26","doi-asserted-by":"publisher","first-page":"7122","DOI":"10.1167\/iovs.15-17440","volume":"56","author":"T Mizutani","year":"2015","unstructured":"Mizutani T, Fowler BJ, Kim Y, Yasuma R, Krueger LA, Gelfand BD et al (2015) Nucleoside reverse transcriptase inhibitors suppress laser-induced choroidal neovascularization in mice. Invest Ophthalmol Vis Sci 56:7122\u20137129. https:\/\/doi.org\/10.1167\/iovs.15-17440","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10178_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 10:89. https:\/\/doi.org\/10.1186\/s13643-021-01626-4","journal-title":"Syst Rev"},{"key":"10178_CR28","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1177\/19417381251364686","volume":"17","author":"D Dagher","year":"2025","unstructured":"Dagher D, Khan M (2025) Writing a systematic review and meta-analysis: a step-by-step guide. Sports Health 17:885\u2013890. https:\/\/doi.org\/10.1177\/19417381251364686","journal-title":"Sports Health"},{"key":"10178_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 14:43. https:\/\/doi.org\/10.1186\/1471-2288-14-43","journal-title":"BMC Med Res Methodol"},{"key":"10178_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/art.10712","volume":"48","author":"MC Montesinos","year":"2003","unstructured":"Montesinos MC, Desai A, Delano D, Chen JF, Fink JS, Jacobson MA et al (2003) Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68. Arthritis Rheum 48:240\u2013247. https:\/\/doi.org\/10.1002\/art.10712","journal-title":"Arthritis Rheum"},{"key":"10178_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11302-011-9233-z","volume":"7","author":"E Gendaszewska-Darmach","year":"2011","unstructured":"Gendaszewska-Darmach E, Kucharska M (2011) Nucleotide receptors as targets in the pharmacological enhancement of dermal wound healing. Purinergic Signal 7:193\u2013206. https:\/\/doi.org\/10.1007\/s11302-011-9233-z","journal-title":"Purinergic Signal"},{"key":"10178_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/CWCMR.S84361","volume":"3","author":"H Tr\u00f8strup","year":"2016","unstructured":"Tr\u00f8strup H, Thomsen K, Calum H, H\u00f8iby N, Moser C (2016) Animal models of chronic wound care: The application of biofilms in clinical research, Chronic Wound Care Manag. Res 3:123\u2013132. https:\/\/doi.org\/10.2147\/CWCMR.S84361","journal-title":"Res"},{"key":"10178_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8862953","author":"BCF Nogueira","year":"2020","unstructured":"Nogueira BCF, Campos AK, Alves RS, Sarandy MM, Novaes RD, Esposito D et al (2020) What is the impact of depletion of immunoregulatory genes on wound healing? A systematic review of preclinical evidence. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2020\/8862953","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"10178_CR34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1067-1927.2004.12404.x","volume":"12","author":"RD Galiano","year":"2004","unstructured":"Galiano RD, 5th Michaels J, Dobryansky M, Levine JP, Gurtner GC (2004) Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen. Jul-Aug 12(4):485\u201392. https:\/\/doi.org\/10.1111\/j.1067-1927.2004.12404.x","journal-title":"Wound Repair Regen. Jul-Aug"},{"key":"10178_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2004.10.011","volume":"38","author":"N Kanda","year":"2005","unstructured":"Kanda N, Watanabe S (2005) Regulatory roles of sex hormones in cutaneous biology and immunology. J Dermatol Sci 38:1\u20137. https:\/\/doi.org\/10.1016\/j.jdermsci.2004.10.011","journal-title":"J Dermatol Sci"},{"key":"10178_CR36","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3390\/molecules23030681","volume":"23","author":"W Leppert","year":"2018","unstructured":"Leppert W, Malec-Milewska M, Zajaczkowska R, Wordliczek J (2018) Transdermal and topical drug administration in the treatment of pain. Molecules 23:681. https:\/\/doi.org\/10.3390\/molecules23030681","journal-title":"Molecules"},{"key":"10178_CR37","doi-asserted-by":"publisher","first-page":"e359","DOI":"10.1002\/mco2.359","volume":"4","author":"Y Ai","year":"2023","unstructured":"Ai Y, Wang H, Liu L, Qi Y, Tang S, Tang J et al (2023) Purine and purinergic receptors in health and disease. MedComm 4:e359. https:\/\/doi.org\/10.1002\/mco2.359","journal-title":"MedComm"},{"key":"10178_CR38","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3389\/fphar.2017.00661","volume":"8","author":"G Burnstock","year":"2017","unstructured":"Burnstock G (2017) Purinergic signalling: therapeutic developments. Front Pharmacol 8:661. https:\/\/doi.org\/10.3389\/fphar.2017.00661","journal-title":"Front Pharmacol"},{"key":"10178_CR39","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.3390\/ijms21072305","volume":"21","author":"E Vel\u00e1zquez-Miranda","year":"2020","unstructured":"Vel\u00e1zquez-Miranda E, Molina-Aguilar C, Gonz\u00e1lez-Gallardo A, V\u00e1zquez-Mart\u00ednez O, D\u00edaz-Mu\u00f1oz M, V\u00e1zquez-Cuevas FG (2020) Increased purinergic responses dependent on P2Y2 receptors in hepatocytes from CCl4-treated fibrotic mice. Int J Mol Sci 21:2305. https:\/\/doi.org\/10.3390\/ijms21072305","journal-title":"Int J Mol Sci"},{"key":"10178_CR40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.5021\/ad.2019.31.4.403","volume":"31","author":"TR Kwon","year":"2019","unstructured":"Kwon TR, Han SW, Kim JH, Lee BC, Kim JM, Hong JY et al (2019) Polydeoxyribonucleotides improve diabetic wound healing in mouse animal model for experimental validation. Ann Dermatol 31:403\u2013413. https:\/\/doi.org\/10.5021\/ad.2019.31.4.403","journal-title":"Ann Dermatol"},{"key":"10178_CR41","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.7150\/ijbs.98856","volume":"20","author":"Y Peng","year":"2024","unstructured":"Peng Y, Xiong R, Wang B, Chen X, Ning Y, Zhao Y et al (2024) The essential role of angiogenesis in adenosine A2A receptor deficiency-mediated impairment of wound healing involving c-Ski via the ERK\/CREB pathways. Int J Biol Sci 20:4532\u20134550. https:\/\/doi.org\/10.7150\/ijbs.98856","journal-title":"Int J Biol Sci"},{"key":"10178_CR42","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/978-3-540-89615-9_13","volume":"193","author":"I Feoktistov","year":"2009","unstructured":"Feoktistov I, Biaggioni I, Cronstein BN (2009) Adenosine receptors in wound healing, fibrosis and angiogenesis. Handb Exp Pharmacol 193:383\u2013397. https:\/\/doi.org\/10.1007\/978-3-540-89615-9_13","journal-title":"Handb Exp Pharmacol"},{"key":"10178_CR43","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jfma.2015.07.022","volume":"115","author":"JC Luo","year":"2016","unstructured":"Luo JC, Peng YL, Chen TS, Huo TI, Hou MC, Huang HC et al (2016) Clopidogrel inhibits angiogenesis of gastric ulcer healing via downregulation of vascular endothelial growth factor receptor 2. J Formos Med Assoc 115:764\u2013772. https:\/\/doi.org\/10.1016\/j.jfma.2015.07.022","journal-title":"J Formos Med Assoc"},{"key":"10178_CR44","unstructured":"Gil M, Skopi\u0144ska-R\u00f3zewska E, Radomska D, Demkow U, Skurzak H, Rochowska M et al (1993) Effect of purinergic receptor antagonists suramin and theobromine on tumor-induced angiogenesis in BALB\/c mice. Folia Biol (Praha) 39:63\u201368"},{"key":"10178_CR45","doi-asserted-by":"publisher","first-page":"7145","DOI":"10.3390\/ijms21197145","volume":"21","author":"F Troncoso","year":"2020","unstructured":"Troncoso F, Herlitz K, Acurio J, Aguayo C, Guevara K, Castro FO et al (2020) Advantages in wound healing process in female mice require upregulation of A2A-mediated angiogenesis under the stimulation of 17\u03b2-estradiol. Int J Mol Sci 21:7145. https:\/\/doi.org\/10.3390\/ijms21197145","journal-title":"Int J Mol Sci"},{"key":"10178_CR46","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jvs.2014.06.112","volume":"63","author":"RM McEnaney","year":"2016","unstructured":"McEnaney RM, Shukla A, Madigan MC, Sachdev U, Tzeng E (2016) P2Y2 nucleotide receptor mediates arteriogenesis in a murine model of hind limb ischemia. J Vasc Surg 63:216\u2013225. https:\/\/doi.org\/10.1016\/j.jvs.2014.06.112","journal-title":"J Vasc Surg"},{"key":"10178_CR47","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1056\/NEJMra1205750","volume":"367","author":"HK Eltzschig","year":"2012","unstructured":"Eltzschig HK, Sitkovsky MV, Robson SC (2012) Purinergic signalling during inflammation. N Engl J Med 367:2322\u20132333. https:\/\/doi.org\/10.1056\/NEJMra1205750","journal-title":"N Engl J Med"},{"key":"10178_CR48","doi-asserted-by":"publisher","first-page":"7685","DOI":"10.3390\/ijms22147685","volume":"22","author":"S Pasquini","year":"2021","unstructured":"Pasquini S, Contri C, Borea PA, Vincenzi F, Varani K (2021) Adenosine and inflammation: here, there and everywhere. Int J Mol Sci 22:7685. https:\/\/doi.org\/10.3390\/ijms22147685","journal-title":"Int J Mol Sci"},{"key":"10178_CR49","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0898-6568(03)00112-8","volume":"15","author":"CM Wang","year":"2003","unstructured":"Wang CM, Chang YY, Sun SH (2003) Activation of P2X7 purinoceptor-stimulated TGF-\u03b21 mRNA expression involves PKC\/MAPK signalling pathway in a rat astrocyte cell line. Cell Signal 15:1129\u20131137. https:\/\/doi.org\/10.1016\/S0898-6568(03)00112-8","journal-title":"Cell Signal"},{"key":"10178_CR50","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1096\/fj.99-0508com","volume":"14","author":"G Hask\u00f3","year":"2000","unstructured":"Hask\u00f3 G, Kuhel DG, Chen JF, Schwarzschild MA, Deitch EA, Mabley JG, Marton A, Szab\u00f3 C (2000) Adenosine inhibits IL-12 and TNF-\u03b1 production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J 14:2065\u20132074. https:\/\/doi.org\/10.1096\/fj.99-0508com","journal-title":"FASEB J"},{"key":"10178_CR51","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nature13085","volume":"509","author":"M Idzko","year":"2014","unstructured":"Idzko M, Ferrari D, Eltzschig HK (2014) Nucleotide signalling during inflammation. Nature 509:310\u2013317. https:\/\/doi.org\/10.1038\/nature13085","journal-title":"Nature"},{"key":"10178_CR52","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0002-9440(10)63698-X","volume":"163","author":"G Pinhal-Enfield","year":"2003","unstructured":"Pinhal-Enfield G, Ramanathan M, Hask\u00f3 G, Vogel SN, Salzman AL, Boons GJ, Leibovich SJ (2003) An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A2A receptors. Am J Pathol 163:711\u2013721. https:\/\/doi.org\/10.1016\/S0002-9440(10)63698-X","journal-title":"Am J Pathol"},{"key":"10178_CR53","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.4049\/jimmunol.157.10.4634","volume":"157","author":"G Hask\u00f3","year":"1996","unstructured":"Hask\u00f3 G, Szab\u00f3 C, N\u00e9meth ZH, Kvetan V, Pastores SM, Vizi ES (1996) Adenosine receptor agonists differentially regulate IL-10, TNF-\u03b1, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol 157:4634\u20134640. https:\/\/doi.org\/10.4049\/jimmunol.157.10.4634","journal-title":"J Immunol"},{"key":"10178_CR54","doi-asserted-by":"publisher","first-page":"e10044","DOI":"10.1371\/journal.pone.0010044","volume":"5","author":"S Chigurupati","year":"2010","unstructured":"Chigurupati S, Mughal MR, Chan SL, Arumugam TV, Baharani A, Tang SC et al (2010) A synthetic uric acid analog accelerates cutaneous wound healing in mice. PLoS One 5:e10044. https:\/\/doi.org\/10.1371\/journal.pone.0010044","journal-title":"PLoS One"},{"key":"10178_CR55","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.freeradbiomed.2010.04.031","volume":"49","author":"S Espada","year":"2010","unstructured":"Espada S, Ortega F, Molina-Jij\u00f3n E, Rojo AI, P\u00e9rez-Sen R, Pedraza-Chaverri J et al (2010) The purinergic P2Y\u2081\u2083 receptor activates the Nrf2\/HO-1 axis, and protects against oxidative stress-induced neuronal death, Free Radic. Biol Med 49:416\u2013426. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.04.031","journal-title":"Biol Med"},{"key":"10178_CR56","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd2638","volume":"7","author":"G Hask\u00f3","year":"2008","unstructured":"Hask\u00f3 G, Linden J, Cronstein B, Pacher P (2008) Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7:759\u2013770. https:\/\/doi.org\/10.1038\/nrd2638","journal-title":"Nat Rev Drug Discov"},{"key":"10178_CR57","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/nrc3613","volume":"19","author":"L Antonioli","year":"2019","unstructured":"Antonioli L, Blandizzi C, Pacher P, Hask\u00f3 G (2019) Immunity, inflammation and cancer: a leading role for adenosine. Nat Rev Cancer 19:842\u2013857. https:\/\/doi.org\/10.1038\/nrc3613","journal-title":"Nat Rev Cancer"},{"key":"10178_CR58","doi-asserted-by":"publisher","DOI":"10.3410\/B3-21","volume":"3","author":"BN Cronstein","year":"2011","unstructured":"Cronstein BN (2011) Adenosine receptors and fibrosis: a translational review. F1000 Biol Rep 3:21. https:\/\/doi.org\/10.3410\/B3-21","journal-title":"F1000 Biol Rep"},{"key":"10178_CR59","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1089\/ars.2009.2644","volume":"11","author":"ME Reichelt","year":"2009","unstructured":"Reichelt ME, Shanu A, Willems L, Witting PK, Ellis NA, Blackburn MR, Headrick JP (2009) Endogenous adenosine selectively modulates oxidant stress via the A1 receptor in ischemic hearts. Antioxid Redox Signal 11:2641\u20132650. https:\/\/doi.org\/10.1089\/ars.2009.2644","journal-title":"Antioxid Redox Signal"},{"key":"10178_CR60","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1186\/s12891-021-04569-y","volume":"22","author":"M Chen","year":"2021","unstructured":"Chen M, Chen H, Gu Y, Sun P, Sun J, Yu H et al (2021) P2Y2 promotes fibroblast activation and skeletal muscle fibrosis through AKT, ERK and PKC. BMC Musculoskelet Disord 22:680. https:\/\/doi.org\/10.1186\/s12891-021-04569-y","journal-title":"BMC Musculoskelet Disord"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10178-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-026-10178-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10178-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:05:49Z","timestamp":1793459149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-026-10178-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10178"],"URL":"https:\/\/doi.org\/10.1007\/s11302-026-10178-y","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}],"article-number":"67"}}